Skip to main content
ANVS logo

Annovis Bio, Inc.

ANVSNYSEHealthcareBiotechnology

$0.87Today:- (-)1Y −58.56%

As of Nov 10, 2026 close

Market cap
$32.80M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.62$5.50
Volume (live)
-
Avg. volume (3M)
2.38M

Annovis Bio (ANVS) Stock Price & Financial Analysis

Annovis Bio Stock Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Price & Trading Activity
Day's Range$0.81 - $0.90
52-Week High$5.50
52-Week Low$0.62
Open$0.90
Volume (last close)1.66M
Average Volume (3M)2.38M
Technical Indicators
50-Day MA$1.14
200-Day MA$1.85
1-Year Change−58.56%
Size & Valuation
Market Cap32.80M
Shares Outstanding37.52M
Price to Book (P/B)-7.71
EV/EBITDA-0.38
Dividend Information
Annual Dividend$0.00
Dividend Yield0.00%

Source: Market prices and company fundamentals. Data as of Nov 10, 2026. Data sources and methodology

Compare ANVS with other stocks

Annovis Bio at a Glance

As of the Nov 10, 2026 close, Annovis Bio (ANVS) has a market capitalization of $32.80M.

As of its latest reported balance sheet, it holds $18.73M in cash and securities against $0.00 of debt, a net cash position of $18.73M.

Annovis Bio does not currently pay a dividend.

The share price is down 58.6% over the past year. At $0.87 (the Nov 10, 2026 close) it sits near the bottom of its 52-week range of $0.62 to $5.50, below its 200-day moving average of $1.84.

Frequently Asked Questions About Annovis Bio

What is the current stock price for ANVS?

As of the Nov 10, 2026 close, ANVS stock trades at $0.87. The 52-week range is $0.62–$5.50, with a day range of $0.81–$0.90.

What is the P/E ratio for ANVS?

Annovis Bio has no trailing P/E ratio because it reported a net loss over the last twelve months.

Does ANVS pay dividends?

Annovis Bio does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.

What is the market cap of ANVS?

As of the Nov 10, 2026 close, Annovis Bio's market capitalization is $32.8M, classifying it as a micro-cap company. Annovis Bio operates in the Healthcare sector within the Biotechnology industry.